Newsroom

Here you will find news and press releases of the DZIF as well as our media centre.

Two containers of antiretroviral combination drugs labeled “Darunavir/Cobicistat/Emtricitabine/Tenofoviralafenamide” and “Bictegravir/Emtricitabine/Tenofoviralafenamide” stand on a countertop in a bright hospital corridor.

Dec 8 2025

MHH study investigates treatment safety in cases of late HIV diagnosis

Press Office

If you have any questions about DZIF or specific press releases, you have come to the right place. We will also gladly put you on to the experts in each specific field. Please get in touch with us.

Dr. Nicola Wittekindt

Public Relations Officer

Martina Lienhop

Public Relations Officer

Janna Schmidt

Public Relations Officer

Send mail

Two gloved hands hold a needle with an ampoule containing a clear liquid. The needle is inserted into the upper arm of a patient.

Dec 2 2025

Flu vaccination remains essential—also in light of international case numbers

Reports are currently reaching us from Japan and several countries in Southeast Asia about an increased number of severe cases of illness caused by the A/H3N2 virus. Experts at the German

The newly elected DZIF Excecutive Board (from left): Prof. Dirk Busch, Prof. Susanne Herold, Prof. Marylyn Addo, Prof. Thomas Pietschmann, and Prof. Andreas Peschel

Nov 28 2025

Continuity and a breath of fresh air: New DZIF Executive Board elected

Five outstanding researchers were elected to the Executive Board at the general meeting of the German Center for Infection Research (DZIF). Prof. Dirk Busch, Prof. Andreas Peschel, and Prof. Thomas

Graphical representation of the crystal structures of LecA and tolcapone

Nov 26 2025

Parkinson's drug as basis for new anti-infectives

When the bacterial infects the body, it uses the sugar-binding protein LecA to attach itself to human cells, invade them, and form so-called biofilms. LecA thus plays a

All news

Find Media Content

Press Office

Always up-to-date

Follow us on: